Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
about
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary diseaseImproving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterolA review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challengesImaging lung function in mice using SPECT/CT and per-voxel analysisOutcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitationsFrom proteomics to prescription-the search for COPD biomarkers.Cognitive impairment in chronic obstructive pulmonary disease.Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.Future impact of various interventions on the burden of COPD in Canada: a dynamic population modelPatient-reported dyspnea in COPD reliability and association with stage of diseaseLoci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease.Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.In vivo detection of acinar microstructural changes in early emphysema with (3)He lung morphometryCorrelating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis.Determinants of health-related quality of life among residents with and without COPD in a historically industrialised area.The burden of chronic obstructive pulmonary disease among employed adultsWhat role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population.Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD.Update in chronic obstructive pulmonary disease 2005.Optimizing economic outcomes in the management of COPD.The relationship between exercise tolerance and other outcomes in COPD.Limited functional performance in chronic obstructive pulmonary disease: nature, causes and measurement.Activity limitation and quality of life in COPD.The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important differenceThe impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of lifeAirway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.Markers of early disease and prognosis in COPD.The effect of vitamin D on COPD exacerbation: a double blind randomized placebo-controlled parallel clinical trial.Gender differences in the association between C-reactive protein, lung function impairment, and COPD.Illness perceptions and COPD: an emerging field for COPD patient management.Trachea epithelium as a "canary" for cigarette smoking-induced biologic phenotype of the small airway epithelium.Dual bronchodilation in COPD: lung function and patient-reported outcomes - a review.A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes.Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.Biomarkers, the control panel and personalized COPD medicine.
P2860
Q24235275-DBE58483-D8EA-422C-9D4F-3F9301BE823EQ26851664-F9E9AD20-5E3C-4986-83F6-E350C9A9639FQ26992071-702379CB-AD40-4678-9CCE-ADEA7C4BA1B4Q28482018-62F9DA97-A11A-413B-B7EE-DD8B3CFA4B45Q30480535-259D11DB-A8D7-48AE-B516-F99CD9E290CBQ33509146-0A6F8C18-52BD-4C79-9EF7-290F53613592Q33916282-96912274-A198-4224-9800-C89576726B5CQ33972919-EBDB57CE-1D79-44E3-A9E8-16FF538E53A8Q34447408-FB137780-DB0D-4E99-B9D1-3E02C2F52FCFQ34519035-1B4FB628-1511-404E-AD74-E8E47BCEAC8AQ34535065-A08B309C-F84C-4431-898E-8EF2A7BD4E1FQ34542055-35946E51-4E6C-4AE0-B928-3F1E9E36D668Q35061131-AC55D53C-20E4-4488-910A-6C1405385B2CQ35167397-6658F1F7-C8CF-4B48-A3EE-E843D656EDB9Q35782210-5B601E03-DD7B-4FB5-A1D0-50177DE98BD7Q35868542-6329423E-CF5F-4D3E-9287-71E7BE1746CEQ35885164-C3872028-E2D2-406B-80C1-D5F8CC130822Q36122056-946C28F9-BF8D-4B91-86C8-42FF71583BA2Q36383938-B230BB17-DE99-4E26-AB67-DB0BA33ACF06Q36470462-01396D4F-F8F2-426C-B076-A9DC6C580725Q36859405-D4A94C6E-8980-4C6D-B9C0-89DFA1BBB559Q36923021-08477783-B3C0-47F3-AEB8-60FBB504A0F1Q36923039-35E11321-4554-4BF3-8875-1B67574B4B12Q36923045-2701EDBA-C243-4EDD-9345-C940985FF3B6Q36968860-786840AE-51D5-45FD-BC8B-36E21CAAD8B7Q37042294-624C8B2B-5911-4B88-AB04-A269B4243120Q37115894-800D7D9F-717D-434D-AD1C-DB634F10456EQ37168317-3B097000-7791-4D5C-B041-E9DD72603504Q37212032-D02D7E9C-B4FA-4538-A136-256E797AB163Q37236587-D22F9D09-610A-492A-A855-574376904EA8Q37308171-B73888B0-02F2-4E7B-A1FB-C2034AFEDBA2Q37419691-5E5ACA47-C0FD-4FBF-BACE-1C3E8CC96F5AQ37573177-7A31E244-237A-46FD-9E19-A67CA570A27CQ37638721-A006AF32-C2DF-43CB-BD10-D37C5D06D95BQ37822219-EDCBD027-B1E0-4549-A60F-BF92E932146EQ37937720-1D4BA355-9A23-43F6-A3ED-2B8CC3AE0A6FQ37973657-0BEE796B-1F7F-4C6F-930D-AAB533B3FEDDQ38055149-58C82777-81CE-48C9-89B2-C0B8CB9D286BQ38072277-483CFF68-EE98-49E1-9BE6-297C2F5248B0Q38546748-E5DB3C02-B964-4E8C-B87B-AE2257D23CDD
P2860
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@ast
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@en
type
label
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@ast
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@en
prefLabel
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@ast
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@en
P1476
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
@en
P2093
A G N Agusti
P304
P356
10.1183/09031936.06.00145104
P577
2006-04-01T00:00:00Z